EKB Journal Management System
Keywords = Daclatasvir
Number of Articles: 31
26

Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study

Volume 9, Issue 3, September 2019, Page 224-229
Nada Rady Badawy; Hanaa A. El-Ghamry; Nahla E. El-Gammal
27

Significance of screening antibodies to hepatitis B core antigen among chronic hepatitis C patients before antiviral therapy

Volume 8, Issue 4, December 2018, Page 202-208
Mohamed Fathallah; Amany Moustafa; Mohamed Aboelmagd; Shyma Elkhodary; Mohammed Elhamouly
28

Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt

Volume 8, Issue 4, December 2018, Page 174-181
Nahla E El-Gammal; Noha E Shahin; Abeer Hussein abdelkader
29

A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY

Volume 58, Issue 2, September and October 2018, Page 37-59
Atef El-Gebaly
30

Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years

Volume 72, Issue 10, July 2018, Page 5385-5390
Mahmoud Abd El Majeed Othman; Motaz Mohamed Saied Abd EL Mawjood; Mohamed Osama Aly Aly; Aya Ahmed Morsy El Ghamry
31

THE USE OF DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Volume 68, Issue 68, December 2017, Page 239-254
N. Elarabany; Hend M. Solyman; Tarek A. Besheer; Gamal A. Abd-Allah
First Page Previous Page 1 2 Next Page Last Page